Streamlining Radioembolization for Intrahepatic Cholangiocarcinoma (ISTAR-04)
Streamlining Radioembolization for Intrahepatic Cholangiocarcinoma (IHCC) ≤ 7 cm : Multicenter Prospective Registry Study
Sponsor: Seoul National University Hospital
Terminated
This study was merged with NCT07043387. Thus, this study was terminated.
Other terminated trials from Seoul National University Hospital
- Peripheral T-cell Lymphoma (PTCL) · Phase PHASE2 · Dec 2024
- Central Nervous System Lymphoma · Phase PHASE2 · Sep 2024
- Rectal Cancer, Adenocarcinoma · Phase NA · Aug 2024
- Variant Angina · Jun 2024
- Submucosal Tumor of Gastrointestinal Tract · Jan 2023
See all terminations from Seoul National University Hospital
Other Intrahepatic Cholangiocarcinoma (Icc) trials with similar outcome
Listed as NCT07043348, this observational or N/A phase trial focuses on Intrahepatic Cholangiocarcinoma (Icc) and remains terminated or withdrawn. Sponsored by Seoul National University Hospital, it has been updated 3 times since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
3 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Aug 2025 — Sep 2025 [monthly]
Terminated
Status: Not Yet Recruiting → Terminated
-
Jul 2025 — Aug 2025 [monthly]
Not Yet Recruiting
First recorded
Jun 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Seoul National University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .